Ambrx Biopharma News

Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Ambrx Biopharma Inc AMAM NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,03 1,06% 2,87 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,94 2,80 2,94 2,87 2,84
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.6.202214:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
06.6.202214:00BWAmbrx Biopharma Inc. Appoints Janet Loesberg to Board of..
27.5.202222:05BWAmbrx Biopharma Inc. to Participate in Upcoming Investor..
24.5.202214:50TRMNAmbrx Biopharma (AMAM) Receives a Hold from Goldman Sachs
17.5.202222:05BWAmbrx Biopharma Inc. Appoints Janice Lu, M.D., Ph.D., as..
06.5.202222:05BWAmbrx Biopharma Inc. to Present at Upcoming Investor..
02.5.202222:05BWAmbrx Biopharma Inc. Announces Filing of Annual Report on..
01.5.202218:46TRMNRobert W. Baird Thinks Ambrx Biopharma’s Stock is Going to..
26.4.202222:59EDGARSecurities Registration: Employee Benefit Plan (s-8)
26.4.202222:14EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
26.4.202222:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
26.4.202222:05BWAmbrx Biopharma Inc. Reports Full Year 2021 Financial..
25.4.202222:05BWAmbrx Biopharma Inc. and Quantum Leap Healthcare..
21.4.202222:05BWAmbrx Biopharma Inc. to Release Full Year 2021 Financial..
07.4.202216:07BNZGBenzinga's Top Ratings Upgrades, Downgrades For April 7,..
10.3.202215:50EDGARAmended Statement of Ownership (sc 13g/a)
08.3.202214:00BWAmbrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual..
28.2.202222:05BWAmbrx Biopharma Inc. to Participate in the Cowen 42nd Annual..
15.2.202214:00BWAmbrx Biopharma Inc. Announces Submission of IND Application..
14.2.202221:10EDGARAmended Statement of Ownership (sc 13g/a)
11.2.202222:08EDGARAmended Statement of Ownership (sc 13g/a)
09.2.202215:13EDGARStatement of Ownership (sc 13g)
08.2.202222:13EDGARStatement of Ownership (sc 13g)
07.2.202214:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
07.2.202214:00BWAmbrx Biopharma Inc. Appoints Paul Maier to Board of..
18.1.202222:31EDGARStatement of Ownership (sc 13g)
09.12.202115:38SEEKAmbrx Bio reports positive ARX788 data from early-stage..
09.12.202115:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
09.12.202115:00BWAmbrx Biopharma Inc. Presents Positive Data from Ongoing..
22.11.202115:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
19.11.202122:05BWAmbrx Biopharma Inc. Announces Acceptance of Two Poster..
08.11.202114:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
04.11.202113:24SEEKAmbrx Biopharma gets dosing underway in mid-stage ARX788..
04.11.202113:00BWAmbrx Biopharma Inc. Announces First Patient Dosed in its..
01.11.202121:05BWAmbrx Biopharma Inc. to Present at the 30th Annual Virtual..
28.10.202122:59SEEKAmbrx Biopharma reports 1H results
28.10.202122:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
28.10.202122:05BWAmbrx Biopharma Inc. Reports 1H 2021 Financial Results and..
04.10.202114:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
04.10.202114:00BWAmbrx Announces Positive Data on ARX788 for the Treatment of..
09.9.202122:30BWAmbrx to Participate in Panel Discussion at the H.C...
03.8.202114:18SEEKAmbrx gets dosing underway in early-stage ARX517 cancer..
03.8.202114:00BWAmbrx Announces First Patient Dosed in a Phase 1 Trial for..
16.7.202115:10EDGARSec Staff Action/letter (sec Staff)
16.7.202115:09EDGARSec Staff Action/letter (sec Staff)
13.7.202119:17SEEKBofA starts Ambrx with a buy on antibody-drug conjugates for..
30.6.202114:00BWAmbrx Appoints Sonja Nelson as Chief Financial Officer
Kürzlich von Ihnen besucht
Ambrx Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20220627 05:07:41